Genistein inhibited hypoxia-inducible factor-1α expression induced by hypoxia and cobalt chloride in human retinal pigment epithelium cells

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 27, Issue 3, 2005, Pages 179-184

  Wang, B ^a   Li, H ^a   Yan, H ^a   Xiao, J G ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cobalt chloride; Genistein; Human retinal pigment epithelia cells; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

COBALT CHLORIDE; GENISTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; MOLECULAR MECHANICS; PIGMENT CELL; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; RETINA CELL; RETINA NEOVASCULARIZATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

CELL HYPOXIA; CELL LINE; COBALT; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENISTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROSCOPY, CONFOCAL; PIGMENT EPITHELIUM OF EYE; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 17644428042     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2005.27.3.890875     Document Type: Article

References (35)

1. Lutty, G.A., McLeod, D.S. Retinal vascular development and oxygen-induced retinopathy: A role for adenosine. Prog Retin Eye Res 2003, 22: 95-111.
2. Khan, Z.A., Chakrabarti, S. Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res 2003, 4: 287-301.
3. Meneses, P.I., Hajjar, K.A., Berns, K.I., Duvoisin, R.M. Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model. Gene Ther 2001, 8: 646-8.
4. Ida, H., Tobe, T., Nambu, H., Matsumura, M., Uyama, M., Campochiaro, P.A. RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF. Invest Ophthalmol Vis Sci 2003, 44: 5430-7.
5. Erb, M.H., Sioulis, C.E., Kuppermann, B.D., Osann, K., Wong, C.G. Differential retinal angiogenic response to sustained intravitreal release of VEGF and bFGF in different pigmented rabbit breeds. Curr Eye Res 2002, 24: 245-52.
6. Simo, R., Lecube, A., Segura, R.M., Garcia Arumi, J., Hernandez, C. Free insulin growth factor-1 and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol 2002, 134: 376-82.
7. Juarez, C.P., Muino, J.C., Guglielmone, H. et al. Experimental retinopathy of prematurity: Angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors. Eur J Ophthalmol 2000, 10: 51-9.
8. Shi, Y.H., Fang, W.G. Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol 2004, 10: 1082-7.
9. Semenza, G.L. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 2003, 54: 17-28.
10. Chun, Y.S., Kim, M.S., Park, J.W. Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci 2002, 17: 581-8.
11. Min, J.H., Yang, H., Ivan, M., Gertler, F., Kaelin, W.G., Jr., Pavletich, N.P. Structure of an HIF-1alpha -pVHL complex: Hydroxyproline recognition in signaling. Science. 2002, 296: 1886-9.
12. Marxsen, J.H., Stengel, P., Doege, K. et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4- hydroxylases. Biochem J. 2004, 381: 761-7.
13. Lee, J.W., Bae, S.H., Jeong, J.W., Kim, S.H., Kim, K.W. Hypoxia-inducible factor (HIF-1)alpha: Its protein stability and biological functions. Exp Mol Med 2004, 36: 1-12.
14. Zimmer, M., Doucette, D., Siddiqui, N., Iliopoulos, O. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Mol Cancer Res 2004, 2: 89-95.
15. Garayoa, M., Martinez, A., Lee, S. et al. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000, 14: 848-62.
16. Lewis, M.D., Roberts, B.J. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity. Oncogene 2004, 23: 2315-23.
17. Dixon, R.A., Ferreira, D. Genistein. Phytochemistry 2002, 60: 205-11.
18. Fitzpatrick, L.A. Soy isoflavones: Hope or hype? Maturitas 2003, 44: S21-S29.
19. Munro, I.C., Harwood, M., Hlywka, J.J. et al. Soy isoflavones: A safety review. Nutr Rev 2003, 61: 1-33.
20. Joussen, A.M., Rohrschneider, K., Reichling, J., Kirchhof, B., Kruse, F.E. Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids. Exp Eye Res 2000, 71: 483-7.
21. Wang, B., Zou, Y., Yuan, Z.L., Xiao, J.G. Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. J Ocul Pharmacol Ther 2003, 19: 457-64.
22. Naggar, H., Fei, Y.J., Ganapathy, V., Smith, S.B. Regulation of reduced-folate transporter-1 (RFT-1) by homocysteine and identity of transport systems for homocysteine uptake in retinal pigment epithelial (RPE) cells. Exp Eye Res 2003, 77: 687-97.
23. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 2002, 973: 443-7.
24. Li, P.A., He, Q., Cao, T. et al. Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2004, 120: 115-22.
25. Osborne, N.N., Casson, R.J., Wood, J.P., Chidlow, G., Graham, M., Melena, J. Retinal ischemia: Mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004, 23: 91-147.
26. Salnikow, K., Su, W., Blagosklonny, M.V., Costa, M. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res 2000, 60: 3375-8.
27. Kelly, B.D., Hackett, S.F., Hirota, K. et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003, 93: 1074-81.
28. Ogata, N., Yamanaka, R., Yamamoto, C. et al. Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat. Curr Eye Res 1998, 17: 1087-96.
29. Gao, S., Liu, G.Z., Wang, Z. Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate 2004, 59: 214-25.
30. Jo, E.H., Hong, H.D., Ahn, N.C. et al. Modulations of the Bel-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J Agric Food Chem 2004, 52: 1715-9.
31. Polkowski, K., Popiolkiewicz, J., Krzeczynski, P. et al. Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines. Cancer Lett 2004, 203: 59-69.
32. Fotsis, T., Pepper, M.S., Aktas, E. et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997, 57: 2916-21.
33. Kapiotis, S., Hermann, M., Held, I., Seelos, C., Ehringer, H., Gmeiner, B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 1997, 17: 2868-74.
34. Wang, G.L., Jiang, B.H., Semenza, G.L. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor I. Biochem Biophys Res Commun 1995, 212: 550-6.
35. Buchler, P., Reber, H.A., Buchler, M. et al. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003, 26: 56-64.